vs

Side-by-side financial comparison of ALERUS FINANCIAL CORP (ALRS) and Amarin Corp plc (AMRN). Click either name above to swap in a different company.

ALERUS FINANCIAL CORP is the larger business by last-quarter revenue ($45.2M vs $45.1M, roughly 1.0× Amarin Corp plc). Amarin Corp plc runs the higher net margin — -23.3% vs -73.2%, a 49.9% gap on every dollar of revenue. On growth, ALERUS FINANCIAL CORP posted the faster year-over-year revenue change (18.0% vs 7.0%). Over the past eight quarters, ALERUS FINANCIAL CORP's revenue compounded faster (-2.5% CAGR vs -18.3%).

Alerus Financial Corporation, marketed as simply Alerus, is a chain of financial institutions headquartered in Grand Forks, North Dakota, with locations in North Dakota, Minnesota, Wisconsin, and Arizona. Alerus offers banking, mortgage, wealth management, and retirement services.

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid.

ALRS vs AMRN — Head-to-Head

Bigger by revenue
ALRS
ALRS
1.0× larger
ALRS
$45.2M
$45.1M
AMRN
Growing faster (revenue YoY)
ALRS
ALRS
+11.0% gap
ALRS
18.0%
7.0%
AMRN
Higher net margin
AMRN
AMRN
49.9% more per $
AMRN
-23.3%
-73.2%
ALRS
Faster 2-yr revenue CAGR
ALRS
ALRS
Annualised
ALRS
-2.5%
-18.3%
AMRN

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ALRS
ALRS
AMRN
AMRN
Revenue
$45.2M
$45.1M
Net Profit
$-33.1M
$-10.5M
Gross Margin
Operating Margin
-96.0%
35.5%
Net Margin
-73.2%
-23.3%
Revenue YoY
18.0%
7.0%
Net Profit YoY
-49232.8%
33.0%
EPS (diluted)
$-1.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALRS
ALRS
AMRN
AMRN
Q1 26
$45.1M
Q4 25
$45.2M
$49.2M
Q3 25
$72.6M
$49.7M
Q2 25
$74.8M
$72.7M
Q1 25
$68.8M
$42.0M
Q4 24
$72.2M
$62.3M
Q3 24
$50.9M
$42.3M
Q2 24
$51.4M
$67.5M
Net Profit
ALRS
ALRS
AMRN
AMRN
Q1 26
$-10.5M
Q4 25
$-33.1M
$-1.2M
Q3 25
$16.9M
$-7.7M
Q2 25
$20.3M
$-14.1M
Q1 25
$13.3M
$-15.7M
Q4 24
$-67.0K
$-48.6M
Q3 24
$5.2M
$-25.1M
Q2 24
$6.2M
$1.5M
Gross Margin
ALRS
ALRS
AMRN
AMRN
Q1 26
Q4 25
47.1%
Q3 25
44.7%
Q2 25
69.2%
Q1 25
59.8%
Q4 24
-15.4%
Q3 24
38.5%
Q2 24
63.4%
Operating Margin
ALRS
ALRS
AMRN
AMRN
Q1 26
35.5%
Q4 25
-96.0%
-12.9%
Q3 25
30.4%
-22.4%
Q2 25
35.2%
-22.0%
Q1 25
25.5%
-39.9%
Q4 24
-0.8%
-84.3%
Q3 24
13.4%
-59.5%
Q2 24
15.8%
-0.8%
Net Margin
ALRS
ALRS
AMRN
AMRN
Q1 26
-23.3%
Q4 25
-73.2%
-2.5%
Q3 25
23.3%
-15.6%
Q2 25
27.1%
-19.4%
Q1 25
19.4%
-37.4%
Q4 24
-0.2%
-78.0%
Q3 24
10.2%
-59.4%
Q2 24
12.1%
2.3%
EPS (diluted)
ALRS
ALRS
AMRN
AMRN
Q1 26
Q4 25
$-1.27
$0.00
Q3 25
$0.65
$-0.02
Q2 25
$0.78
$-0.03
Q1 25
$0.52
$-0.04
Q4 24
$-0.06
$-0.12
Q3 24
$0.26
$-0.06
Q2 24
$0.31
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALRS
ALRS
AMRN
AMRN
Cash + ST InvestmentsLiquidity on hand
$67.2M
$307.8M
Total DebtLower is stronger
$59.2M
Stockholders' EquityBook value
$564.9M
Total Assets
$5.2B
$645.8M
Debt / EquityLower = less leverage
0.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALRS
ALRS
AMRN
AMRN
Q1 26
$307.8M
Q4 25
$67.2M
$302.6M
Q3 25
$92.0M
$286.6M
Q2 25
$80.9M
$298.7M
Q1 25
$83.0M
$281.8M
Q4 24
$61.2M
$294.2M
Q3 24
$66.0M
$305.7M
Q2 24
$438.1M
$306.7M
Total Debt
ALRS
ALRS
AMRN
AMRN
Q1 26
Q4 25
$59.2M
Q3 25
$59.2M
Q2 25
$59.1M
Q1 25
$59.1M
Q4 24
$59.1M
Q3 24
$59.0M
Q2 24
$59.0M
Stockholders' Equity
ALRS
ALRS
AMRN
AMRN
Q1 26
Q4 25
$564.9M
$459.3M
Q3 25
$550.7M
$458.9M
Q2 25
$533.2M
$464.9M
Q1 25
$514.2M
$473.7M
Q4 24
$495.4M
$486.2M
Q3 24
$386.5M
$531.4M
Q2 24
$373.2M
$551.9M
Total Assets
ALRS
ALRS
AMRN
AMRN
Q1 26
$645.8M
Q4 25
$5.2B
$670.8M
Q3 25
$5.3B
$659.8M
Q2 25
$5.3B
$670.1M
Q1 25
$5.3B
$655.7M
Q4 24
$5.3B
$685.3M
Q3 24
$4.4B
$750.6M
Q2 24
$4.4B
$799.9M
Debt / Equity
ALRS
ALRS
AMRN
AMRN
Q1 26
Q4 25
0.10×
Q3 25
0.11×
Q2 25
0.11×
Q1 25
0.11×
Q4 24
0.12×
Q3 24
0.15×
Q2 24
0.16×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALRS
ALRS
AMRN
AMRN
Operating Cash FlowLast quarter
$67.5M
Free Cash FlowOCF − Capex
$58.8M
FCF MarginFCF / Revenue
130.2%
Capex IntensityCapex / Revenue
19.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$102.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALRS
ALRS
AMRN
AMRN
Q1 26
Q4 25
$67.5M
$15.3M
Q3 25
$32.8M
$-12.7M
Q2 25
$10.7M
$16.6M
Q1 25
$7.7M
$-12.5M
Q4 24
$21.7M
$-13.3M
Q3 24
$20.2M
$-2.4M
Q2 24
$-12.5M
$-2.7M
Free Cash Flow
ALRS
ALRS
AMRN
AMRN
Q1 26
Q4 25
$58.8M
Q3 25
$30.3M
Q2 25
$7.6M
Q1 25
$5.7M
Q4 24
$9.4M
Q3 24
$17.4M
Q2 24
$-16.1M
FCF Margin
ALRS
ALRS
AMRN
AMRN
Q1 26
Q4 25
130.2%
Q3 25
41.8%
Q2 25
10.1%
Q1 25
8.2%
Q4 24
13.0%
Q3 24
34.2%
Q2 24
-31.4%
Capex Intensity
ALRS
ALRS
AMRN
AMRN
Q1 26
Q4 25
19.3%
Q3 25
3.4%
Q2 25
4.2%
Q1 25
3.0%
Q4 24
17.1%
Q3 24
5.4%
Q2 24
7.2%
Cash Conversion
ALRS
ALRS
AMRN
AMRN
Q1 26
Q4 25
Q3 25
1.94×
Q2 25
0.53×
Q1 25
0.58×
Q4 24
Q3 24
3.88×
Q2 24
-2.01×
-1.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALRS
ALRS

Other$17.3M38%
Retirement And Benefit Services$17.3M38%
Wealth Management$7.4M16%
Mortgage Banking$3.2M7%

AMRN
AMRN

U.S$35.6M79%
Europe$4.9M11%
Rest-of-World (ROW)$2.8M6%
Licensing & Royalties$1.8M4%

Related Comparisons